Uncapped with Jack AltmanConcentrating in Winners | Vince Hankes, Partner at Thrive Capital | Ep. 27
Jack Altman and Vince Hankes on thrive Capital’s playbook for concentrated, conviction-led venture investing at scale.
In this episode of Uncapped with Jack Altman, featuring Vince Hankes and Jack Altman, Concentrating in Winners | Vince Hankes, Partner at Thrive Capital | Ep. 27 explores thrive Capital’s playbook for concentrated, conviction-led venture investing at scale Thrive grew from a small, New York-based outsider fund into a platform capable of writing billion-dollar checks, while trying to preserve its contrarian, high-conviction culture.
At a glance
WHAT IT’S REALLY ABOUT
Thrive Capital’s playbook for concentrated, conviction-led venture investing at scale
- Thrive grew from a small, New York-based outsider fund into a platform capable of writing billion-dollar checks, while trying to preserve its contrarian, high-conviction culture.
- Hankes argues that concentration requires “dogmatic conviction,” built through long wind-up periods of relationship-building, deep qualitative diligence, and then quantitative validation.
- He details Thrive’s barbell approach (early + platform/growth) and explains why mid-stage “large check venture” can be the most perilous due to competition and capital-loss risk.
- The conversation also covers Thrive’s Carvana trade, conflict management in a concentrated portfolio, and where AI value accrues—plus why life sciences and robotics may be the biggest long-term AI opportunities.
IDEAS WORTH REMEMBERING
5 ideasConcentration demands near-absolute conviction—and time is the price.
Thrive’s biggest checks come after long relationship “wind-ups” (e.g., ~10 years from first Stripe investment to a $2B check; ~18 months getting to know Isomorphic). This duration is treated as a core input to conviction, not a luxury.
Start qualitative, then use numbers to confirm—not to inspire.
Hankes says leading with metrics can create fragile confidence when growth decelerates. Thrive forms a qualitative hypothesis around people/product/customers first, then uses data to validate it—so short-term misses don’t automatically break the thesis.
Thrive’s growth funds are intentionally designed to be small-N portfolios.
He describes an “ideal growth fund” as ~10 companies, aiming to map fund construction to the power law. The firm keeps investor headcount low (about eight investors) to avoid deal proliferation and dilution of conviction.
The best odds may be backing $10B companies on the path to $100B+, not picking unicorns early.
Hankes cites a growing number of $100B+ outcomes and argues it can be easier to identify “generational platform” trajectories at scale than to select a breakout from thousands of earlier-stage contenders.
Mid-stage ‘large-check venture’ is a danger zone when $100M checks meet uncertain PMF.
He’s skeptical of the heavily funded $500M–$2B segment where many companies are priced like they have PMF even when it’s unproven. At $100M check sizes, “zeros” are hard to survive, making capital-loss risk central.
WORDS WORTH SAVING
5 quotesWhen you write a billion dollars into a company, you have to have conviction… almost dogmatic conviction.
— Vince Hankes
Our philosophy is we start with the qualitative… and then the hypothesis has to be confirmed by the quantitative.
— Vince Hankes
It’s a lot easier to predict the long term than it is the short term.
— Vince Hankes
The vast majority of dollars of enterprise value that get created are in the second or third decade of a company.
— Vince Hankes
Today… 120% of the profit in AI is from NVIDIA.
— Vince Hankes
QUESTIONS ANSWERED IN THIS EPISODE
5 questionsOn the ‘qualitative first, quantitative second’ framework: what are the specific qualitative signals that most reliably predict long-term platform outcomes?
Thrive grew from a small, New York-based outsider fund into a platform capable of writing billion-dollar checks, while trying to preserve its contrarian, high-conviction culture.
You mentioned the ‘wind-up period’ can be years—how do you operationalize that without creating confirmation bias or relationship-based overcommitment?
Hankes argues that concentration requires “dogmatic conviction,” built through long wind-up periods of relationship-building, deep qualitative diligence, and then quantitative validation.
Thrive targets ~10 growth positions—what’s the internal bar for adding the 11th, and what metrics or thesis-breakers cause you to exit instead?
He details Thrive’s barbell approach (early + platform/growth) and explains why mid-stage “large check venture” can be the most perilous due to competition and capital-loss risk.
In the Stripe 2023 round, what were the 2–3 key objections other investors raised, and what evidence most changed their minds (or didn’t)?
The conversation also covers Thrive’s Carvana trade, conflict management in a concentrated portfolio, and where AI value accrues—plus why life sciences and robotics may be the biggest long-term AI opportunities.
Carvana: what were the concrete operating ‘levers’ you tracked to decide the turnaround was real before doubling down near the lows?
Chapter Breakdown
Building conviction to write billion-dollar checks: years-long “wind-up”
Vince explains that extreme concentration requires near-dogmatic conviction, which can’t be formed quickly. Thrive’s biggest checks often come after years of relationship-building and iterative learning with a company.
Thrive’s evolution: from scrappy $10M beginnings to a scaled platform
Jack and Vince walk through Thrive’s growth from a tiny 2009 fund into a multi-billion-dollar firm. Vince highlights how the firm felt small even at a billion-dollar fund, especially relative to his prior seat at Tiger.
New York outsider DNA and early talent selection
Vince argues Thrive’s early New York positioning and “outsider” status shaped both its culture and its recruiting—attracting contrarian, self-selecting talent. As Thrive became more well-known, preserving that contrarian edge became harder and more intentional.
Origin of concentrated boldness: Instagram and GitHub as formative case studies
Vince uses Instagram and GitHub to show that large, proportional bets and deep partnership have been core to Thrive since early days. These stories also reinforce how non-consensus moments can create opportunities to build conviction and ownership.
Stripe’s 2023 “non-consensus” mega-round: long-term lens over short-term numbers
Vince reframes Thrive’s Stripe investment as contrarian in context: post-COVID deceleration and skepticism about profitability and leadership. Thrive underwrote the long-term compounding of online commerce and deepened diligence beyond quarterly metrics, then helped syndicate the full raise.
Thrive’s decision framework: qualitative-first, then quantitative confirmation
Vince outlines Thrive’s sequencing: start with people, product, and customers to form a hypothesis, then validate with data. This approach is designed to keep conviction resilient through inevitable quarterly volatility.
Why Databricks was compelling: single-product to multi-product platform transition
Vince describes Thrive’s Databricks investment as driven less by generic “AI tailwinds” and more by a platform inflection. The core bet: multi-product platform companies are structurally underpriced because they’re harder to build and scale than single-product businesses.
A concentrated growth fund by design: 10-company portfolios and power-law math
Vince explains Thrive’s preference for highly concentrated growth funds—ideally around 10 companies—aligned with power-law outcomes. He argues it can be easier to identify a $10B company becoming $100B+ than to pick the right unicorn from thousands earlier on.
Why winners are getting bigger: second-decade compounding, scale flywheels, and talent
Vince attributes today’s mega-winners to compounding over decades, not sudden changes. The biggest enterprise value creation often occurs in a company’s second or third decade, when distribution, product expansion, and talent flywheels become self-reinforcing.
What works in venture now: barbell strategy and skepticism of the crowded middle
Vince describes Thrive’s barbell approach: early-stage where ownership and hands-on help can be high, and late-stage where platforms are clearer. He’s most wary of the mid-stage ‘breakout’ zone where large checks meet uncertainty and intense competition.
Operating model at scale: few investors, few deals, and creating opportunities (not waiting)
Vince explains why Thrive’s headcount and process look unusual: a small investing team makes relatively few commitments per person each year. The firm emphasizes proactive, relationship-driven investing—approaching companies with deep outside-in knowledge rather than waiting for a fundraising process.
Scale as an advantage: the billion-dollar check narrows the competitive field
Vince argues that the ability to write extremely large checks grants access and reduces competition versus mid-stage rounds. Thrive prefers competing in arenas with fewer capable firms, where time-intensive partnership is feasible and welcomed by companies.
Carvana: contrarian public markets bet, organizational resilience, and doubling down at the bottom
Vince recounts Thrive’s Carvana investment as a high-volatility test of their conviction culture. Thrive focused on product and operational levers during a cycle-driven collapse, then increased exposure when risk-reward improved—despite intense mark-to-market pressure.
Full-stack investing tradeoffs: conflicts, commitment, and building new structures (AI accounting example)
Vince discusses how Thrive manages conflicts given its concentrated approach and willingness to invest across stages (seed through public). He illustrates how full-stack thinking led Thrive to back an AI-enabled accounting service strategy and raise a dedicated holding-company vehicle to match the time horizon.
AI outlook: augmentation over full replacement, plus big bets in life science, codegen economics, vertical apps, and robotics
Vince shares his AI worldview: many roles will be augmented rather than fully automated, though some functions (e.g., support) may shift heavily to software. He highlights life science as an underappreciated frontier, breaks down codegen’s value chain economics, assesses vertical AI workspaces, and frames robotics as a potentially massive but timing-uncertain opportunity.
EVERY SPOKEN WORD
Install uListen for AI-powered chat & search across the full episode — Get Full Transcript
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome